Company intelligence / Profile preview

Silatha

Ownership: Private
Development stage: Other

Overview

Silatha delivers measurable improvements in psychological safety, engagement, retention rates, and productivity through science-led behavioral change programs. Reported outcomes include 92% improved psychological safety and 93% higher company engagement among participants.

Therapeutic areas: PsychiatryWomen's HealthOther
Modalities: Non-pharmacological therapyDigital health platformBehavioral science-based interventionsEmployee support programs
Industry: Consulting

Partnerships

Has worked with major corporations including Nike, Unilever, Kraft Heinz; no formal pharma/biotech partnerships reported.

Beyond the preview

Go deeper on Silatha.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Silatha.

Explore the full profile